Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New bioimaging collaboration to bolster infectious disease research
The collaboration will greatly improve the UK's national capabilities

Electron microscopes will allow more detailed study of viral diseases

The Pirbright Institute and Diamond Light Source have announced a new-five year collaboration that will allow both institutions to make advancements in their research. This agreement will improve research and innovation identified by the UK Research and Innovation (UKRI) infrastructure programme.

Pirbright’s head of bioimaging Professor Pippa Hawes will be working at both sites, helping to prepare Pirbright research projects for high resolution electron microscopy and contributing to Diamond’s development initiatives.

Commenting on the agreement, Prof Hawes says: “There is a lot of preparatory work that can be carried out at Pirbright with our microscopes. We can use them to really define the questions we need to answer and then ensure we have samples prepared in a way that will maximise their use at Diamond.”

Diamond, the UK’s national synchrotron, has an embedded cryo-electron microscope facility, known as Electron Bio-Imaging Centre (eBIC). These powerful microscopes are capable of solving protein molecular structures to below 0.3 nm resolution, and are well suited to projects that involve understanding the cell biology of virus-host interactions, as well as how viruses replicate.

The microscopes have also enabled the design of a new vaccine for the foot-and-mouth disease virus (FMDV), through allowing Pirbright scientists to view the outer shell of the vaccine. This vaccine has recently been licensed for further development.

Director of Pirbright, Bryan Charleston comments: “A long and productive association between Pirbright and Diamond exists that has resulted in vital research developments such as the visualisation of the FMDV capsid, bluetongue virus and bovine antibody structures. We hope this agreement will aid our ambition to understand the biology of high consequence viruses and expand the range of programmes exploring solutions to control current and emerging problems.”

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.